Leslie Nan Gold, Age 6277 Concord Ave, White Plains, NY 10606

Leslie Gold Phones & Addresses

77 Concord Ave, White Plains, NY 10606 (914) 946-2706

107 Sterling Ave, Harrison, NY 10528

14926 82Nd St, Howard Beach, NY 11414

77 Concord Ave, White Plains, NY 10606

Work

Company: Kidz central station May 2013 Position: Vice president of operations and director of legal affairs

Education

School / High School: New York University School of Law- New York, NY May 2008 Specialities: J.D.

Ranks

Licence: New York - Due to reregister within 30 days of birthday Date: 2009

Mentions for Leslie Nan Gold

Career records & work history

Lawyers & Attorneys

Leslie Gold Photo 1

Leslie Marie Gold, New York NY - Lawyer

Address:
Morrison Cohen LLP
909 3Rd Ave, New York, NY 10022
(212) 735-8789 (Office)
Licenses:
New York - Due to reregister within 30 days of birthday 2009
Education:
Nyu
Leslie Gold Photo 2

Leslie Gold - Lawyer

ISLN:
907037048
Admitted:
1981
University:
Oberlin College, A.B.
Law School:
George Washington University, J.D.
Leslie Gold Photo 3

Leslie Gold - Lawyer

Office:
Law Offices of Leslie S. Gold
Specialties:
Chapter 11 Bankruptcy, Commercial, Commercial Litigation, Business Bankruptcy
ISLN:
901568173
Admitted:
1991
University:
University of California at Los Angeles, B.A., 1988
Law School:
University of California, Hastings College of the Law, J.D., 1991

Leslie Gold resumes & CV records

Resumes

Leslie Gold Photo 39

Guest Host At Fox News Radio

Location:
Greater New York City Area
Industry:
Broadcast Media
Leslie Gold Photo 40

Leslie Gold

Leslie Gold Photo 41

Leslie Gold

Leslie Gold Photo 42

Leslie Gold - New York, NY

Work:
Kidz Central Station May 2013 to 2000
Vice President of Operations and Director of Legal Affairs
Morrison Cohen LLP - New York, NY Feb 2011 to Dec 2013
Corporate and Intellectual Property Associate
Paul, Weiss, Rifkind, Wharton & Garrison LLP - New York, NY Sep 2008 to Jan 2011
Corporate Associate
Linklaters - New York, NY May 2007 to Aug 2007
Summer Associate
Transitional Justice Institute - Belfast, IE May 2006 to Aug 2006
Research Intern
Lehman, Lee & Xu Jan 2005 to May 2005
Intern
Chambers of Hon - Washington, DC Sep 2004 to Dec 2004
Judge Inez Smith Reid
Education:
New York University School of Law - New York, NY May 2008
J.D.

Publications & IP owners

Wikipedia

Leslie Gold Photo 43

The Radio Chick

The Radio Chick is the on-air name for Leslie Gold, an American radio personality whose talk show features comedian Chuck Nice and her producer, Paul "Butch"

Us Patents

Tissue-Derived Tumor Growth Inhibitors, Methods Of Preparation And Uses Thereof

US Patent:
6559123, May 6, 2003
Filed:
Aug 22, 1994
Appl. No.:
08/294061
Inventors:
Kenneth K. Iwata - Westbury NY
John R. Stephenson - Santa Cruz CA
Leslie I. Gold - New York NY
Assignee:
OSI Pharmaceuticals, Inc. - Uniondale NY
International Classification:
A61K 3800
US Classification:
514 12, 514 2, 514 21, 424 851, 530326, 530350, 530351, 530399, 530412, 530413, 530416, 530417, 435 694
Abstract:
This invention is directed to a method of treating a burn or healing a wound in a mammal by administering a chromatographically recovered polypeptide having the N-terminal amino acid sequence Ala-Leu-Asp-Thr-Asn-Tyr-Cys-Phe-Arg-Asn-Leu-Glu-Glu-Asn-Cys-Cys-Val. This polypeptide is known as TGI, TGI-1 and TGI-2. It is also referred to as TGF-3. The invention is also directed to a compositions which comprises the chromatographically recovered polypeptide. The invention also provides a pharmaceutical compositions to inhibit the growth of epithelial cells or heal a wound or treat a burn consisting of the chromatographically recovered polypeptide.

Tissue-Derived Tumor Growth Inhibitor

US Patent:
6586394, Jul 1, 2003
Filed:
Jan 27, 1994
Appl. No.:
08/188197
Inventors:
Kenneth K. Iwata - Westbury NY
John R. Stephenson - Santa Cruz CA
Leslie I. Gold - New York NY
Assignee:
OSI Pharmaceuticals, Inc. - Uniondale NY
International Classification:
A61K 3818
US Classification:
514 12, 530350, 530351, 530399, 530412, 530413, 530416, 530417
Abstract:
This invention is directed to a chromatographically recovered polypeptide having the N-terminal amino acid sequence Ala-Leu-Asp-Thr-Asn-Tyr-Cys-Phe-Arg-Asn-Leu-Glu-Clu-Asn-Cys-Cys-Val. This polypeptide is known as TGI, TGI-1 and TGI-2. It is also referred to as TGF-3. The invention is also directed to a compositions which comprises the chromatographically recovered polypeptide. The invention also provides a pharmaceutical compositions to inhibit the growth of epithelial cells or heal a wound or treat a burn consisting of the chromatographically recovered polypeptide. The invention is also directed to methods which comprise administering to a subject an effective amount of the chromatographically recovered so as to thereby inhibit the growth of epithelial cells, or heal the wound or treat the burn.

Methods For Treating Diabetic Wounds

US Patent:
8129341, Mar 6, 2012
Filed:
Aug 25, 2009
Appl. No.:
12/547256
Inventors:
Leslie I. Gold - New York NY, US
Marek Michalak - Edmonton, CA
Assignee:
New York University - New York NY
Calregen Inc. - Harrison NY
International Classification:
A61K 38/16
A61K 38/18
US Classification:
514 76, 530399
Abstract:
The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment.

Methods For Treating Diabetic Wounds

US Patent:
2013004, Feb 21, 2013
Filed:
Feb 6, 2012
Appl. No.:
13/367039
Inventors:
Leslie I. Gold - New York NY, US
Marek Michalak - Edmonton, CA
Assignee:
CALREGEN INC. - Harrison NY
NEW YORK UNIVERSITY - New York NY
International Classification:
A61K 38/17
A61P 17/02
A61K 38/18
US Classification:
514 81, 514 11, 514 82, 514 91, 514 96, 514 89, 514 186, 514 172
Abstract:
The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment.

Therapeutic And Cosmetic Uses And Applications Of Calreticulin

US Patent:
2013015, Jun 13, 2013
Filed:
Jun 17, 2011
Appl. No.:
13/717349
Inventors:
Leslie I. Gold - New York NY, US
Marek Michalak - Edmonton, CA
Assignee:
CALREGEN INC. - Harrison NY
NEW YORK UNIVERSITY - New York NY
International Classification:
A61K 38/17
A61K 8/73
A61Q 19/08
A61K 8/64
US Classification:
514 24, 514 188, 514 165, 514 167, 514 171, 514 186, 514 212, 514 207, 514 208, 514 76, 514 82, 514 81, 514 91, 514 96, 514 89
Abstract:
Therapeutic and cosmetic uses and applications of calreticulin are provided. In particular, the invention relates to therapeutic and cosmetic uses and applications of calreticulin to a patient in need of such treatment including in tissue repair, wound healing, ulcers, reducing scar formation, and reducing or eliminating wrinkles.

Fibrin-Binding Peptide Fragments Of Fibronectin

US Patent:
5792742, Aug 11, 1998
Filed:
Aug 1, 1994
Appl. No.:
8/283857
Inventors:
Leslie I. Gold - New York NY
Agueda A. Rostagno - Elmhurst NY
Martin Baron - Oxford, GB
Iain D. Campbell - Oxford, GB
Michael J. Williams - Oxford, GB
Assignee:
New York University - New York NY
Isis Innovation Ltd. - Oxford
International Classification:
C07K 1478
A61K 3839
US Classification:
514 2
Abstract:
Fibrin-binding molecules are provided which include at least one peptide essentially corresponding to one or both of the following portions of the natural fibronectin molecule. The first portion is that portion which includes the. sup. 4 F1. sup. 5 F1 module pair of fibronectin and includes no more of the natural fibronectin molecule than the N-terminal 25. 9 kDa proteolytic fragment. The second portion includes the. sup. 10 F1. sup. 11 F1 module pair of fibronectin and includes no more of the natural fibronectin molecule than the C-terminal 11 kDa proteolytic fragment. Also disclosed are nucleic acid molecules encoding the fibrin-binding peptides, methods for making the peptides, methods for using the peptides in the diagnosis and treatment of cardiovascular, peripheral vascular, cerebrovascular, and other conditions associated with fibrin deposition, and assay methods for detecting a fibrin-binding molecule and for measuring fibrin.

Beneficial Wound Healing Applications Of Calreticulin And Other Hyaluronan-Associated Proteins

US Patent:
5591716, Jan 7, 1997
Filed:
Nov 19, 1993
Appl. No.:
8/155933
Inventors:
John W. Siebert - New York NY
Hari G. Garg - Belmont MA
Leslie I. Gold - New York NY
Assignee:
New York University - New York NY
The General Hospital Corp. - Boston MA
International Classification:
A61K 3816
A61K 3818
US Classification:
514 12
Abstract:
Hyaluronan associated proteins, in particular calreticulin, promote the accelerated and relatively scarless healing of wounds. Methods for treating wounds using such proteins, and pharmaceutical compositions comprising such proteins, are provided.

Generation Of Native Recombinant Secreted Human Endoplasmic Reticulum Chaperones By Using Their Native Signal Sequences In Yeast Expression Systems

US Patent:
2015019, Jul 9, 2015
Filed:
Jan 12, 2015
Appl. No.:
14/594485
Inventors:
- Vilnius, LT
Rimantas Slibinskas - Vilnius, LT
Kestutis Sasnauskas - Vilnius, LT
Marek Michalak - Edmonton, CA
Leslie Ina Gold - Darien CT, US
Assignee:
UAB BALTYMAS - Vilnius
International Classification:
C12N 9/90
C07K 14/47
Abstract:
A method using yeast as a host for production of human ER chaperone proteins, using endogenous signal peptides of intracellular human proteins that are recognized and correctly processed in the yeast cells to subsequently lead to the secretion of the human proteins. The resultant proteins possessed native amino acid sequence and were biologically active. Moreover, secretion allowed simple one-step purification of native recombinant human proteins with high yields.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.